Competitive Technologies

U.S. solicitor general recommends LabCorp's petition in patent case be denied

Published in Medicine and Law Weekly, September 30th, 2005

Competitive Technologies, Inc. (CTT) announced that the U.S. solicitor general's office, on behalf of the United States, has recommended in its brief filed with the U.S. Supreme Court that the petition for a writ of certiorari filed by Laboratory Corporation of America Holdings d/b/a LabCorp, be denied.

The petition had been filed by LabCorp in its attempt to overcome an infringement ruling in a homocysteine assay patent case in which CTT's patent rights and those of its clients had been upheld by both the U.S. District Court and the Court of Appeals of the Federal Circuit.

The homocysteine patent was derived from discoveries made by CTT's clients...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-09-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry